Precision Business Insights has published a report on the global lung cancer screening market, estimating its value at USD 16.3 billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 7.9% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/lung-cancer-screening-market      

The market refers to the industry focused on medical procedures and technologies designed to detect lung cancer in its early stages, often before symptoms appear. The primary screening method used is low-dose computed tomography (LDCT), which employs lower radiation levels than standard CT scans to identify small nodules or cancers in the lungs

The lung cancer screening market is driven by several key factors:

• Rising Awareness Programs: Increased efforts to educate people about the benefits of early detection are boosting demand for lung cancer screening.
• Technological Advancements: Innovations such as low-dose computed tomography (LDCT) and biomarker-based screening methods are improving accuracy and accessibility.
• Government Initiatives: Many governments and healthcare organizations are promoting screening programs to reduce lung cancer mortality rates.
• Increasing Smoking Population: Since smoking is a major risk factor for lung cancer, the growing number of smokers worldwide is driving the need for early detection

The global lung cancer screening market segmentation:
1) By Cancer Type: Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer
2) By Diagnosis Type: Low Dose Spiral CT scan, And Chest X-Ray
3) By End-Users: Hospital & Clinics and Diagnostic Centers

Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=64857

Regional Overview:
The report also examines the current concerns and their Future Effects on the lung cancer screening market by the region. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.

• North America (U.S., Canada)
• Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
• Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
• Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

The competitive landscape is dominated by major players like PenRad Technologies Inc., Koninklijke Philips N.V, Volpara Health Limited, Thynk Health, Nuance Communications, Inc., Siemens Healthcare GmbH, MyCareWare, Inc., MagView, MeVis Medical Solutions AG, Canon Medical Informatics, Inc.

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747